vs

Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Bitcoin Depot Inc. is the larger business by last-quarter revenue ($162.5M vs $83.1M, roughly 2.0× PROCEPT BioRobotics Corp). Bitcoin Depot Inc. runs the higher net margin — 3.4% vs -38.1%, a 41.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 20.1%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -4.9%).

Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

BTM vs PRCT — Head-to-Head

Bigger by revenue
BTM
BTM
2.0× larger
BTM
$162.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+0.1% gap
PRCT
20.2%
20.1%
BTM
Higher net margin
BTM
BTM
41.5% more per $
BTM
3.4%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-4.9%
BTM

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BTM
BTM
PRCT
PRCT
Revenue
$162.5M
$83.1M
Net Profit
$5.5M
$-31.6M
Gross Margin
64.9%
Operating Margin
7.3%
-4.1%
Net Margin
3.4%
-38.1%
Revenue YoY
20.1%
20.2%
Net Profit YoY
690.4%
-27.9%
EPS (diluted)
$0.08
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTM
BTM
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$162.5M
$83.3M
Q2 25
$172.1M
$79.2M
Q1 25
$164.2M
$69.2M
Q4 24
$68.2M
Q3 24
$135.3M
$58.4M
Q2 24
$163.1M
$53.4M
Net Profit
BTM
BTM
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$5.5M
$-21.4M
Q2 25
$6.1M
$-19.6M
Q1 25
$4.2M
$-24.7M
Q4 24
$-18.9M
Q3 24
$-939.0K
$-21.0M
Q2 24
$-2.6M
$-25.6M
Gross Margin
BTM
BTM
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
BTM
BTM
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
7.3%
-27.8%
Q2 25
9.2%
-28.0%
Q1 25
10.8%
-39.7%
Q4 24
-28.9%
Q3 24
4.1%
-38.4%
Q2 24
4.7%
-50.3%
Net Margin
BTM
BTM
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
3.4%
-25.7%
Q2 25
3.5%
-24.7%
Q1 25
2.6%
-35.8%
Q4 24
-27.6%
Q3 24
-0.7%
-35.9%
Q2 24
-1.6%
-48.0%
EPS (diluted)
BTM
BTM
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$0.08
$-0.38
Q2 25
$0.16
$-0.35
Q1 25
$0.20
$-0.45
Q4 24
$-0.34
Q3 24
$-0.05
$-0.40
Q2 24
$-0.13
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTM
BTM
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$59.3M
$245.6M
Total DebtLower is stronger
$67.5M
$51.7M
Stockholders' EquityBook value
$21.0M
$347.7M
Total Assets
$125.3M
$487.1M
Debt / EquityLower = less leverage
3.21×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTM
BTM
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$59.3M
$294.3M
Q2 25
$48.0M
$302.7M
Q1 25
$35.0M
$316.2M
Q4 24
$333.7M
Q3 24
$32.2M
$196.8M
Q2 24
$43.9M
$214.1M
Total Debt
BTM
BTM
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$67.5M
$51.6M
Q2 25
$66.5M
$51.5M
Q1 25
$56.2M
$51.5M
Q4 24
$51.5M
Q3 24
$44.5M
$51.4M
Q2 24
$41.2M
$51.4M
Stockholders' Equity
BTM
BTM
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$21.0M
$380.3M
Q2 25
$4.7M
$385.8M
Q1 25
$-4.6M
$389.2M
Q4 24
$402.2M
Q3 24
$-7.9M
$241.2M
Q2 24
$4.4M
$251.8M
Total Assets
BTM
BTM
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$125.3M
$511.5M
Q2 25
$109.1M
$513.1M
Q1 25
$89.7M
$519.4M
Q4 24
$534.0M
Q3 24
$87.4M
$374.1M
Q2 24
$97.5M
$374.4M
Debt / Equity
BTM
BTM
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
3.21×
0.14×
Q2 25
14.18×
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
9.27×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTM
BTM
PRCT
PRCT
Operating Cash FlowLast quarter
$6.6M
Free Cash FlowOCF − Capex
$2.5M
FCF MarginFCF / Revenue
1.6%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
1.20×
TTM Free Cash FlowTrailing 4 quarters
$27.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTM
BTM
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$6.6M
$-6.6M
Q2 25
$10.2M
$-15.0M
Q1 25
$16.3M
$-17.0M
Q4 24
$-32.4M
Q3 24
$5.8M
$-18.8M
Q2 24
$10.1M
$-15.7M
Free Cash Flow
BTM
BTM
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$2.5M
$-9.5M
Q2 25
$9.8M
$-17.8M
Q1 25
$15.9M
$-18.8M
Q4 24
$-33.6M
Q3 24
$-1.0M
$-19.0M
Q2 24
$7.6M
$-16.8M
FCF Margin
BTM
BTM
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
1.6%
-11.4%
Q2 25
5.7%
-22.5%
Q1 25
9.7%
-27.2%
Q4 24
-49.2%
Q3 24
-0.8%
-32.6%
Q2 24
4.7%
-31.4%
Capex Intensity
BTM
BTM
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
2.5%
3.4%
Q2 25
0.2%
3.5%
Q1 25
0.2%
2.7%
Q4 24
1.7%
Q3 24
5.0%
0.4%
Q2 24
1.5%
2.0%
Cash Conversion
BTM
BTM
PRCT
PRCT
Q1 26
Q4 25
Q3 25
1.20×
Q2 25
1.67×
Q1 25
3.88×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTM
BTM

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons